Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Trial watch: The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors.

Literature DB >> 30482962

Trial watch: The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors.

Jun Tang¹, Jia Xin Yu¹, Vanessa M Hubbard-Lucey¹, Svetoslav T Neftelinov², Jeffrey P Hodge², Yunqing Lin².

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2018 PMID： 30482962 DOI： 10.1038/nrd.2018.210

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

× No keyword cloud information.

1 in total

1. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Authors: Jedd D Wolchok; Vanna Chiarion-Sileni; Rene Gonzalez; Piotr Rutkowski; Jean-Jacques Grob; C Lance Cowey; Christopher D Lao; John Wagstaff; Dirk Schadendorf; Pier F Ferrucci; Michael Smylie; Reinhard Dummer; Andrew Hill; David Hogg; John Haanen; Matteo S Carlino; Oliver Bechter; Michele Maio; Ivan Marquez-Rodas; Massimo Guidoboni; Grant McArthur; Celeste Lebbé; Paolo A Ascierto; Georgina V Long; Jonathan Cebon; Jeffrey Sosman; Michael A Postow; Margaret K Callahan; Dana Walker; Linda Rollin; Rafia Bhore; F Stephen Hodi; James Larkin
Journal: N Engl J Med Date: 2017-09-11 Impact factor: 91.245

1 in total

125 in total

1. Neurotoxicities associated with immune checkpoint inhibitor therapy.

Authors: Sophie L Duong; Frank J Barbiero; Richard J Nowak; Joachim M Baehring
Journal: J Neurooncol Date: 2021-01-17 Impact factor: 4.130

2. Immune checkpoint inhibition: from molecules to clinical application.

Authors: L S Taams; T D de Gruijl
Journal: Clin Exp Immunol Date: 2020-05 Impact factor: 4.330

3. Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7.

Authors: Simon Wisnovsky; Leonhard Möckl; Stacy A Malaker; Kayvon Pedram; Gaelen T Hess; Nicholas M Riley; Melissa A Gray; Benjamin A H Smith; Michael C Bassik; W E Moerner; Carolyn R Bertozzi
Journal: Proc Natl Acad Sci U S A Date: 2021-02-02 Impact factor: 11.205

4. Targeting DNA Repair to Drive Immune Responses: It's Time to Reconsider the Strategy for Clinical Translation.

Authors: Nobuyuki Takahashi; Ira Surolia; Anish Thomas
Journal: Clin Cancer Res Date: 2020-02-17 Impact factor: 12.531

5. Normalization Cancer Immunotherapy for Melanoma.

Authors: Matthew D Vesely; Lieping Chen
Journal: J Invest Dermatol Date: 2020-02-22 Impact factor: 8.551

Review 6. Nasopharyngeal carcinoma: an evolving paradigm.

Authors: Kenneth C W Wong; Edwin P Hui; Kwok-Wai Lo; Wai Kei Jacky Lam; David Johnson; Lili Li; Qian Tao; Kwan Chee Allen Chan; Ka-Fai To; Ann D King; Brigette B Y Ma; Anthony T C Chan
Journal: Nat Rev Clin Oncol Date: 2021-06-30 Impact factor: 66.675

7. The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression.

Authors: Florent Petitprez; Sacha Levy; Cheng-Ming Sun; Maxime Meylan; Christophe Linhard; Etienne Becht; Nabila Elarouci; David Tavel; Lubka T Roumenina; Mira Ayadi; Catherine Sautès-Fridman; Wolf H Fridman; Aurélien de Reyniès
Journal: Genome Med Date: 2020-10-06 Impact factor: 11.117